A new oral antiviral drug for COVID is being tested in humans – can it make a difference?

By Filipa Henderson Sousa, Postdoctoral Research Fellow in Infectious Diseases, Edinburgh Napier University
Peter Barlow, Professor of Immunology and Infection, Edinburgh Napier University

Despite the effectiveness of vaccines, we still need drugs to treat COVID. Even people who have been double vaccinated stand a small chance of getting COVID and ending up moderately or even severely ill. There are drugs to treat COVID, but they have to be given in hospital.

One promising drug that could improve things is molnupiravir, an antiviral that’s moving into the final…

Read complete article

~	The chilling effects of trying to report on the Israel-Gaza war

~	Beauty giant Sephora has returned to the UK after nearly 20 years – by betting on AI and gen Z

~	Scotland is ditching its flagship 2030 climate goal – why legally binding targets really matter

~	Snorkelling artists showcase Scotland’s diverse marine life in thought-provoking exhibition

~	Russia and the Taliban: here’s why Putin wants to get closer to Afghanistan’s current rulers

~	Illmatic at 30: how Nas invented epistolary rap – and changed the hyper-masculine world of hip hop forever

~	Friend breakups: why they can sometimes feel as bad as falling out of love

~	Sky-high waiting times don’t make people trust the NHS any less – why that’s potentially bad news for Rishi Sunak

~	How India’s economy has fared under ten years of Narendra Modi

~	High and dry: Federal budget 2024 misses the mark on water-related investments